Biological Trace Element Research

, Volume 21, Issue 1, pp 119–129 | Cite as

Regulation of the isoforms of metallothionein

  • Curtis D. Klaassen
  • Lois D. Lehman-McKeeman
Section 2 Metal Binding Proteins and Metal Resistance

Abstract

The objective of this research was to study the regulation of hepatic MT-I and MT-II in rats. Induction of MTs following Cd, Zn, and glucocorticoid treatments was studied in adult rats and the ontogeny of MTs was evaluated in developing rats. The isoforms were quantitated by anion-exchange HPLC and their respective mRNAs were evaluated by Northern blot hybridization with mouse cRNA probes. In untreated adult rat liver, MT-II was more abundant than MT-I. Cd treatment increased MT-I and MT-II to similar concentrations. Low dosages of Zn increased MT-II levels three times higher than MT-I levels, whereas higher dosages increased the isoforms to similar levels, whereas higher dosages increased the isoforms to similar levels. Differences in the degradation of Zn-induced MTs were observed: apparent half-lives for MT-I and MT-II were 12.2 and 21.9 h, respectively. MT-II was the predominant glucocorticoid-inducible isoform. MT-I and MT-II mRNAs increased coordinately after glucocorticoid treatment, but MT-II mRNA was more abundant than MT-I mRNA. In immature rats, MT-I and MT-II were first detected in fetal liver on gestation day 18 and increased to maximum hepatic concentrations during the first week postpartum. Thereafter, MT levels decreased, reaching adult levels by 35 d. In contrast, MT mRNAs reached maximal levels during late gestation that were maintained throughout the first three weeks postpartum. Discoordination between MT mRNA and protein levels is suggestive of translational control of MTs in developing rats. In summary, MT-II is more abundant than MT-I in untreated rats and in rats treated with glucocorticoids or low dosages of zinc. In addition to transcriptional regulations of MTs, translational control of MTs may be important in regulating hepatic MT concentrations, particularly in developing rats, and differences in the degradation of MT-I and MT-II may influence tissue concentrations of the isoforms.

Index Entries

Isometallothioneins metallothioneins, induction of metallothioneins, regulation of metallothioneins, ontogeny of 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    R. J. Cousins,J., Inherited Metab. Dis. 6 (Suppl. 1), 15 (1983).CrossRefGoogle Scholar
  2. 2.
    A.-P. Leber and T. S. Miya,Toxicol. Appl. Pharmacol. 37, 403 (1976).PubMedCrossRefGoogle Scholar
  3. 3.
    M. Karin,Cell 41, 9 (1985).PubMedCrossRefGoogle Scholar
  4. 4.
    M. G. Cherian,Biochem. Biophys. Res. Commun. 61, 920 (1974).PubMedCrossRefGoogle Scholar
  5. 5.
    D. R. Winge, K. B. Nielson, R. D. Zeikus, and W. R. Gray,J. Biol. Chem. 259, 11419 (1984).PubMedGoogle Scholar
  6. 6.
    D. H. Hamer,Ann. Rev. Biochem. 55, 913 (1986).PubMedGoogle Scholar
  7. 7.
    L. D. Lehman and C. D. Klaassen,Anal. Biochem. 153, 305 (1986).PubMedCrossRefGoogle Scholar
  8. 8.
    L. D. Lehman-McKeeman, G. K. Andrews, and C. D. Klaassen,Biochem. J. 249 429 (1988).PubMedGoogle Scholar
  9. 9.
    L. D. Lehman-McKeeman, G. K. Andrews, and C. D. Klaassen,Toxicol. Appl. Pharmacol. 92, 1 (1988).PubMedCrossRefGoogle Scholar
  10. 10.
    L. D. Lehman-McKeeman, G. K. Andrews, and C. D. Klaassen,Toxicol. Appl. Pharmacol. 92, 10 (1988).PubMedCrossRefGoogle Scholar
  11. 11.
    L. D. Lehman-McKeeman and C. D. Klaassen,Toxicol. Appl. Pharmacol. 88, 195 (1987).PubMedCrossRefGoogle Scholar
  12. 12.
    M. Webb,The Chemistry, Biochemistry and Biology of Cadmium, M. Webb, ed., Elsevier-North Holland, Amsterdam/New York, 1979, pp. 195–266.Google Scholar
  13. 13.
    K. T. Suzuki and M. Yamamura,Toxicol. Lett. 6, 59 (1980).PubMedCrossRefGoogle Scholar
  14. 14.
    K. T. Suzuki and M. Yamamura,Biochem. Pharmacol. 29, 2260 (1984).CrossRefGoogle Scholar
  15. 15.
    K. Cain and B. L. Griffiths,Biochem. J. 217, 85 (1984).PubMedGoogle Scholar
  16. 16.
    J. E. Piletz, R. D. Andersen, B. W. Birren, and H. R. Herschman,Eur. J. Biochem. 131, 489 (1983).PubMedCrossRefGoogle Scholar
  17. 17.
    M. D. Enger, C. E. Hilderbrand, J. Seagrave, and R. A. Tobey,Cadmium, E. C. Foulkes, ed., Springer-Verlag, New York, 1986, pp. 363–396.Google Scholar

Copyright information

© The Humana Press Inc. 1989

Authors and Affiliations

  • Curtis D. Klaassen
    • 1
  • Lois D. Lehman-McKeeman
    • 1
  1. 1.Department of Pharmacology, Toxicology and TherapeuticsUniversity of Kansas Medical CenterKansas City

Personalised recommendations